CD48 and cancer: In addition, using the TCGA cancer RNA-seq dataset and TIMER31, we found that the expression of CD48 and KDM6A was positively correlated with intertumoral NK cell abundance in many human cancer types, suggesting that KDM6A and CD48 affect NK-mediated tumor immunity in a variety of human cancers (Supplementary Fig. 4i,j).